$180.54
+1.58 (+0.88%)
Last updated: Apr 16, 2026 00:42
Fundamentals Overview
Biogen Inc. is near the high of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+326.6% upside vs price
Profitability
Risk (Beta)
0.16 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +326.6% upside vs price · Analyst grade: A-
Pressures (Sell):
Sentiment weakening (2 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 7, Equal Weight: 4, Hold: 4, Market Perform: 2, Neutral: 8, Outperform: 3, Reduce: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $770.27; current price is $180.54. That’s a +326.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 20.48 |
| DCF value (model) | $770.27 (326.6% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.45 |
| P/S (TTM) | 2.7 |
| P/FCF (TTM) | 12.39 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.68 |
| Quick Ratio (TTM) | 2.03 |
| Cash Ratio (TTM) | 0.9 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 13.18% |
| Gross margin (TTM) | 70.47% |
| Operating margin (TTM) | 19.14% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for BIIB.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2026-04-10 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-04-02 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-04-01 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-04-01 |
| HSBC | maintain | Reduce | Reduce | 2026-03-17 |
| Freedom Broker | maintain | Hold | Hold | 2026-02-23 |
| Wedbush | maintain | Neutral | Neutral | 2026-02-10 |
| Wedbush | maintain | Neutral | Neutral | 2026-02-09 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-09 |
| Guggenheim | maintain | Buy | Buy | 2026-02-09 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-09 |
| Piper Sandler | maintain | Neutral | Neutral | 2026-02-09 |
| TD Cowen | maintain | Buy | Buy | 2026-02-09 |
| JP Morgan | maintain | Neutral | Neutral | 2026-02-09 |
| Truist Securities | maintain | Hold | Hold | 2026-02-09 |
| RBC Capital | maintain | Outperform | Outperform | 2026-02-09 |
| BMO Capital | maintain | Market Perform | Market Perform | 2026-02-09 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-02-09 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2026-02-09 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-01-30 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-27 |
| Truist Securities | maintain | Hold | Hold | 2026-01-08 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-07 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-12-12 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-12-10 |
| HSBC | downgrade | Hold | Reduce | 2025-12-10 |
| Piper Sandler | maintain | Neutral | Neutral | 2025-11-21 |
| Freedom Broker | downgrade | Buy | Hold | 2025-11-06 |
| Stifel | upgrade | Hold | Buy | 2025-11-06 |
| Bernstein | maintain | Market Perform | Market Perform | 2025-11-03 |